Clincosm LogoSign in Get a demo

Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Terminated
CT.gov ID
NCT00184210
Collaborator
The Research Council of Norway (Other), The Norwegian Women´s Public Health Association (Other)
1,000
Enrollment
1
Location
251
Actual Duration (Months)
4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed by other methods, such as histopathology.

The MR spectral profiles are compared to clinical findings such as the patients diagnosis, lymph node status and tumor size.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    HR MAS MR Spectroscopy of Breast Cancer Tissue
    Actual Study Start Date :
    Jan 1, 2000
    Actual Primary Completion Date :
    Dec 1, 2020
    Actual Study Completion Date :
    Dec 1, 2020

    Outcome Measures

    Primary Outcome Measures

    1. MRimage of breast cancer tissue [0 hour]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Palpable breast cancer lesion

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Norwegian University of Technology and Science Trondheim Norway 7491

    Sponsors and Collaborators

    • Norwegian University of Science and Technology
    • The Research Council of Norway
    • The Norwegian Women´s Public Health Association

    Investigators

    • Study Chair: Tone F Bathen, PhD, Norwegian University of Technology and Science

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Norwegian University of Science and Technology
    ClinicalTrials.gov Identifier:
    NCT00184210
    Other Study ID Numbers:
    • 154080/I30
    First Posted:
    Sep 16, 2005
    Last Update Posted:
    Mar 22, 2021
    Last Verified:
    Mar 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Norwegian University of Science and Technology
    Magnetic Resonance Spectroscopy
    Additional relevant MeSH terms:
    Breast Neoplasms

    Study Results

    No Results Posted as of Mar 22, 2021